Literature DB >> 22513715

Four parameters increase the sensitivity and specificity of the exon array analysis and disclose 25 novel aberrantly spliced exons in myotonic dystrophy.

Yoshihiro Yamashita1, Tohru Matsuura, Jun Shinmi, Yoshinobu Amakusa, Akio Masuda, Mikako Ito, Masanobu Kinoshita, Hirokazu Furuya, Koji Abe, Tohru Ibi, Ko Sahashi, Koo Sahashi, Kinji Ohno.   

Abstract

Myotonic dystrophy type 1 (DM1) is an RNA gain-of-function disorder in which abnormally expanded CTG repeats of DMPK sequestrate a splicing trans-factor MBNL1 and upregulate another splicing trans-factor CUGBP1. To identify a diverse array of aberrantly spliced genes, we performed the exon array analysis of DM1 muscles. We analyzed 72 exons by RT-PCR and found that 27 were aberrantly spliced, whereas 45 were not. Among these, 25 were novel and especially splicing aberrations of LDB3 exon 4 and TTN exon 45 were unique to DM1. Retrospective analysis revealed that four parameters efficiently detect aberrantly spliced exons: (i) the signal intensity is high; (ii) the ratio of probe sets with reliable signal intensities (that is, detection above background P-value=0.000) is high within a gene; (iii) the splice index (SI) is high; and (iv) SI is deviated from SIs of the other exons that can be estimated by calculating the deviation value (DV). Application of the four parameters gave rise to a sensitivity of 77.8% and a specificity of 95.6% in our data set. We propose that calculation of DV, which is unique to our analysis, is of particular importance in analyzing the exon array data.

Entities:  

Mesh:

Year:  2012        PMID: 22513715     DOI: 10.1038/jhg.2012.37

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  10 in total

1.  The RNA-binding protein Rbfox1 regulates splicing required for skeletal muscle structure and function.

Authors:  Simona Pedrotti; Jimena Giudice; Adan Dagnino-Acosta; Mark Knoblauch; Ravi K Singh; Amy Hanna; Qianxing Mo; John Hicks; Susan Hamilton; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2015-01-09       Impact factor: 6.150

2.  Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.

Authors:  Linda L Bachinski; Keith A Baggerly; Valerie L Neubauer; Tamara J Nixon; Olayinka Raheem; Mario Sirito; Anna K Unruh; Jiexin Zhang; Lalitha Nagarajan; Lubov T Timchenko; Guillaume Bassez; Bruno Eymard; Josep Gamez; Tetsuo Ashizawa; Jerry R Mendell; Bjarne Udd; Ralf Krahe
Journal:  Neuromuscul Disord       Date:  2013-11-15       Impact factor: 4.296

3.  RNA toxicity and missplicing in the common eye disease fuchs endothelial corneal dystrophy.

Authors:  Jintang Du; Ross A Aleff; Elisabetta Soragni; Krishna Kalari; Jinfu Nie; Xiaojia Tang; Jaime Davila; Jean-Pierre Kocher; Sanjay V Patel; Joel M Gottesfeld; Keith H Baratz; Eric D Wieben
Journal:  J Biol Chem       Date:  2015-01-15       Impact factor: 5.157

Review 4.  REVIEW: Current understanding of the pathogenesis of Fuchs' endothelial corneal dystrophy.

Authors:  Gargi Gouranga Nanda; Debasmita Pankaj Alone
Journal:  Mol Vis       Date:  2019-06-05       Impact factor: 2.367

5.  Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes.

Authors:  Kumpei Tanisawa; Eri Mikami; Noriyuki Fuku; Yoko Honda; Shuji Honda; Ikuro Ohsawa; Masafumi Ito; Shogo Endo; Kunio Ihara; Kinji Ohno; Yuki Kishimoto; Akihito Ishigami; Naoki Maruyama; Motoji Sawabe; Hiroyoshi Iseki; Yasushi Okazaki; Sanae Hasegawa-Ishii; Shiro Takei; Atsuyoshi Shimada; Masanori Hosokawa; Masayuki Mori; Keiichi Higuchi; Toshio Takeda; Mitsuru Higuchi; Masashi Tanaka
Journal:  BMC Genomics       Date:  2013-04-15       Impact factor: 3.969

6.  RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1.

Authors:  Roscoe Klinck; Angélique Fourrier; Philippe Thibault; Johanne Toutant; Mathieu Durand; Elvy Lapointe; Marie-Laure Caillet-Boudin; Nicolas Sergeant; Geneviève Gourdon; Giovanni Meola; Denis Furling; Jack Puymirat; Benoit Chabot
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

7.  Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients.

Authors:  Aymeric Ravel-Chapuis; Amanda Klein Gunnewiek; Guy Bélanger; Tara E Crawford Parks; Jocelyn Côté; Bernard J Jasmin
Journal:  Mol Biol Cell       Date:  2016-03-30       Impact factor: 4.138

8.  Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.

Authors:  Lucie Picchio; Vincent Legagneux; Stephane Deschamps; Yoan Renaud; Sabine Chauveau; Luc Paillard; Krzysztof Jagla
Journal:  Dis Model Mech       Date:  2018-05-21       Impact factor: 5.758

9.  Identification of Qk as a Glial Precursor Cell Marker that Governs the Fate Specification of Neural Stem Cells to a Glial Cell Lineage.

Authors:  Akihide Takeuchi; Yuji Takahashi; Kei Iida; Motoyasu Hosokawa; Koichiro Irie; Mikako Ito; J B Brown; Kinji Ohno; Kinichi Nakashima; Masatoshi Hagiwara
Journal:  Stem Cell Reports       Date:  2020-09-24       Impact factor: 7.765

Review 10.  An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I.

Authors:  Andrea López-Martínez; Patricia Soblechero-Martín; Laura de-la-Puente-Ovejero; Gisela Nogales-Gadea; Virginia Arechavala-Gomeza
Journal:  Genes (Basel)       Date:  2020-09-22       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.